Health Canada issues treatment failure warning for GSK’s COVID therapy amid BA.2 subvariant
TORONTO — Health Canada is alerting health care providers that a COVID-19 monoclonal antibody therapy treatment may no longer be effective against the new subvariant of Omicron. The agency reported …
Read More